메뉴 건너뛰기




Volumn 16, Issue 2 SUPPL., 2007, Pages 159-165

Adjuvant treatment of elderly breast cancer patients

Author keywords

Adjuvant therapy; Age; Breast cancer; Co morbidity; Elderly

Indexed keywords

ANASTROZOLE; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; IBANDRONIC ACID; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN; TRASTUZUMAB;

EID: 35648964109     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.07.026     Document Type: Article
Times cited : (21)

References (59)
  • 3
    • 4644265882 scopus 로고    scopus 로고
    • Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node negative breast cancer
    • Hebert-Croteau N., Brisson J., Latreille J., Rivard M., Abdelaziz N., and Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node negative breast cancer. J Clin Oncol 22 (2004) 3685-3693
    • (2004) J Clin Oncol , vol.22 , pp. 3685-3693
    • Hebert-Croteau, N.1    Brisson, J.2    Latreille, J.3    Rivard, M.4    Abdelaziz, N.5    Martin, G.6
  • 4
    • 33645362243 scopus 로고    scopus 로고
    • Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden
    • Eaker S., Dickman P.W., Bergkvist L., and Holmberg L. Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med 3 (2006) e25
    • (2006) PLoS Med , vol.3
    • Eaker, S.1    Dickman, P.W.2    Bergkvist, L.3    Holmberg, L.4
  • 5
    • 0034894204 scopus 로고    scopus 로고
    • Cancer mortality in the elderly, 1960-1998: a worldwide approach
    • La Vecchia C., Lucchini F., Negri E., and Levi F. Cancer mortality in the elderly, 1960-1998: a worldwide approach. Oncol Spectrums 2 (2001) 386-394
    • (2001) Oncol Spectrums , vol.2 , pp. 386-394
    • La Vecchia, C.1    Lucchini, F.2    Negri, E.3    Levi, F.4
  • 7
    • 35649008185 scopus 로고    scopus 로고
    • National center for health and statistics. Tables on trends in health and aging; life expectancy. 〈www.cdc.gov〉, 2007 [report].
  • 8
    • 0034607235 scopus 로고    scopus 로고
    • Tumor characteristics and clinical outcome of elderly women with breast cancer
    • Diab S.G., Elledge R.M., and Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92 (2000) 550-556
    • (2000) J Natl Cancer Inst , vol.92 , pp. 550-556
    • Diab, S.G.1    Elledge, R.M.2    Clark, G.M.3
  • 9
    • 0037334579 scopus 로고    scopus 로고
    • Primary breast cancer in elderly women: biological profile and relation with clinical outcome
    • Daidone M.G., Coradini D., Martelli G., and Veneroni S. Primary breast cancer in elderly women: biological profile and relation with clinical outcome. Crit Rev Oncol Hematol 45 (2003) 313-325
    • (2003) Crit Rev Oncol Hematol , vol.45 , pp. 313-325
    • Daidone, M.G.1    Coradini, D.2    Martelli, G.3    Veneroni, S.4
  • 11
    • 0034063101 scopus 로고    scopus 로고
    • Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis
    • Whelan T.J., Julian J., Wright J., Jadad A.R., and Levine M.L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
    • (2000) J Clin Oncol , vol.18 , pp. 1220-1229
    • Whelan, T.J.1    Julian, J.2    Wright, J.3    Jadad, A.R.4    Levine, M.L.5
  • 12
    • 33750615608 scopus 로고    scopus 로고
    • Postmastectomy radiation and survival in older women with breast cancer
    • Smith B.D., Haffty B.G., Hurria A., Galusha D.H., and Gross C.P. Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol 24 (2006) 4901-4907
    • (2006) J Clin Oncol , vol.24 , pp. 4901-4907
    • Smith, B.D.1    Haffty, B.G.2    Hurria, A.3    Galusha, D.H.4    Gross, C.P.5
  • 13
    • 1042280379 scopus 로고    scopus 로고
    • Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality
    • Vinh-Hung V., and Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96 (2004) 115-121
    • (2004) J Natl Cancer Inst , vol.96 , pp. 115-121
    • Vinh-Hung, V.1    Verschraegen, C.2
  • 14
    • 0034690745 scopus 로고    scopus 로고
    • Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000;355:1757-70.
  • 15
    • 29144475553 scopus 로고    scopus 로고
    • Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
    • Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
    • (2005) Lancet , vol.366 , pp. 2087-2106
    • Clarke, M.1    Collins, R.2    Darby, S.3    Davies, C.4    Elphinstone, P.5    Evans, E.6
  • 16
    • 4344628403 scopus 로고    scopus 로고
    • Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer
    • Hughes K.S., Schnaper L.A., Berry D., Cirrincione C., McCormick B., Shank B., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351 (2004) 971-977
    • (2004) N Engl J Med , vol.351 , pp. 971-977
    • Hughes, K.S.1    Schnaper, L.A.2    Berry, D.3    Cirrincione, C.4    McCormick, B.5    Shank, B.6
  • 17
    • 19344364880 scopus 로고    scopus 로고
    • Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717.
  • 18
    • 11444251764 scopus 로고    scopus 로고
    • Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
    • Howell A., Cuzick J., Baum M., Buzdar A., Dowsett M., Forbes J.F., et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365 (2005) 60-62
    • (2005) Lancet , vol.365 , pp. 60-62
    • Howell, A.1    Cuzick, J.2    Baum, M.3    Buzdar, A.4    Dowsett, M.5    Forbes, J.F.6
  • 19
    • 33947510501 scopus 로고    scopus 로고
    • Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
    • Coates A.S., Keshaviah A., Thurlimann B., Mouridsen H., Mauriac L., Forbes J.F., et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 25 (2007) 486-492
    • (2007) J Clin Oncol , vol.25 , pp. 486-492
    • Coates, A.S.1    Keshaviah, A.2    Thurlimann, B.3    Mouridsen, H.4    Mauriac, L.5    Forbes, J.F.6
  • 20
    • 10744223655 scopus 로고    scopus 로고
    • A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
    • Coombes R.C., Hall E., Gibson L.J., Paridaens R., Jassem J., Delozier T., et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350 (2004) 1081-1092
    • (2004) N Engl J Med , vol.350 , pp. 1081-1092
    • Coombes, R.C.1    Hall, E.2    Gibson, L.J.3    Paridaens, R.4    Jassem, J.5    Delozier, T.6
  • 21
    • 23444446523 scopus 로고    scopus 로고
    • Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
    • Jakesz R., Jonat W., Gnant M., Mittlboeck M., Greil R., Tausch C., et al. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366 (2005) 455-462
    • (2005) Lancet , vol.366 , pp. 455-462
    • Jakesz, R.1    Jonat, W.2    Gnant, M.3    Mittlboeck, M.4    Greil, R.5    Tausch, C.6
  • 23
    • 24744450378 scopus 로고    scopus 로고
    • Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17
    • Goss P.E., Ingle J.N., Martino S., Robert N.J., Muss H.B., Piccart M.J., et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 97 (2005) 1262-1271
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1262-1271
    • Goss, P.E.1    Ingle, J.N.2    Martino, S.3    Robert, N.J.4    Muss, H.B.5    Piccart, M.J.6
  • 24
    • 20044382779 scopus 로고    scopus 로고
    • American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004
    • Winer E.P., Hudis C., Burstein H.J., Wolff A.C., Pritchard K.I., Ingle J.N., et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 23 (2005) 619-629
    • (2005) J Clin Oncol , vol.23 , pp. 619-629
    • Winer, E.P.1    Hudis, C.2    Burstein, H.J.3    Wolff, A.C.4    Pritchard, K.I.5    Ingle, J.N.6
  • 25
    • 33745528525 scopus 로고    scopus 로고
    • Use and outcomes of adjuvant chemotherapy in older women with breast cancer
    • Giordano S.H., Duan Z., Kuo Y.F., Hortobagyi G.N., and Goodwin J.S. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 24 (2006) 2750-2756
    • (2006) J Clin Oncol , vol.24 , pp. 2750-2756
    • Giordano, S.H.1    Duan, Z.2    Kuo, Y.F.3    Hortobagyi, G.N.4    Goodwin, J.S.5
  • 26
    • 19944422061 scopus 로고    scopus 로고
    • A multigene assay to predict recurrence of tamoxifen-treated, node negative breast cancer
    • Paik S., Shak S., Tang G., Kim C., Baker J., Cronin M., et al. A multigene assay to predict recurrence of tamoxifen-treated, node negative breast cancer. N Engl J Med 351 (2004) 2817-2826
    • (2004) N Engl J Med , vol.351 , pp. 2817-2826
    • Paik, S.1    Shak, S.2    Tang, G.3    Kim, C.4    Baker, J.5    Cronin, M.6
  • 27
    • 33744814477 scopus 로고    scopus 로고
    • Gene expression and benefit of chemotherapy in women with node negative, estrogen receptor-positive breast cancer
    • Paik S., Tang G., Shak S., Kim C., Baker J., Kim W., et al. Gene expression and benefit of chemotherapy in women with node negative, estrogen receptor-positive breast cancer. J Clin Oncol 24 (2006) 3726-3734
    • (2006) J Clin Oncol , vol.24 , pp. 3726-3734
    • Paik, S.1    Tang, G.2    Shak, S.3    Kim, C.4    Baker, J.5    Kim, W.6
  • 28
    • 20044388527 scopus 로고    scopus 로고
    • Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer
    • Muss H.B., Woolf S., Berry D., Cirrincione C., Weiss R.B., Budman D., et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293 (2005) 1073-1081
    • (2005) JAMA , vol.293 , pp. 1073-1081
    • Muss, H.B.1    Woolf, S.2    Berry, D.3    Cirrincione, C.4    Weiss, R.B.5    Budman, D.6
  • 29
    • 16544369385 scopus 로고    scopus 로고
    • Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial
    • Fargeot P., Bonneterre J., Roche H., Lortholary A., Campone M., Van P.I., et al. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial. J Clin Oncol 22 (2004) 4622-4630
    • (2004) J Clin Oncol , vol.22 , pp. 4622-4630
    • Fargeot, P.1    Bonneterre, J.2    Roche, H.3    Lortholary, A.4    Campone, M.5    Van, P.I.6
  • 32
    • 35648961161 scopus 로고    scopus 로고
    • Slamon D, Eiermann W, Robert N, et al. 2nd interim analysis phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab with docetaxel, carboplatin and trastuzumab in Her2neu postiive early breast cancer patients. San Antonio Breast Cancer Symposium 2006 (Abstract 52) see www.sabcs.org.
  • 33
    • 17044460539 scopus 로고    scopus 로고
    • Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
    • Crivellari D., Bonetti M., Castiglione-Gertsch M., Gelber R.D., Rudenstam C.M., Thurlimann B., et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol 18 (2000) 1412-1422
    • (2000) J Clin Oncol , vol.18 , pp. 1412-1422
    • Crivellari, D.1    Bonetti, M.2    Castiglione-Gertsch, M.3    Gelber, R.D.4    Rudenstam, C.M.5    Thurlimann, B.6
  • 34
    • 85074742863 scopus 로고    scopus 로고
    • Toxicity of older and younger patients treated with intensive adjuvant chemotherapy for node-positive breast cancer: the CALGB experience
    • [abstract]
    • Muss H., Berry D., Cirrincione C., et al. Toxicity of older and younger patients treated with intensive adjuvant chemotherapy for node-positive breast cancer: the CALGB experience. Proc Annu Meet Am Soc Clin Oncol 24 (2006) 17s [abstract]
    • (2006) Proc Annu Meet Am Soc Clin Oncol , vol.24
    • Muss, H.1    Berry, D.2    Cirrincione, C.3
  • 35
    • 0037319948 scopus 로고    scopus 로고
    • Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting
    • Repetto L., Carreca I., Maraninchi D., Aapro M., Calabresi P., and Balducci L. Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting. Crit Rev Oncol Hematol 45 (2003) 123-128
    • (2003) Crit Rev Oncol Hematol , vol.45 , pp. 123-128
    • Repetto, L.1    Carreca, I.2    Maraninchi, D.3    Aapro, M.4    Calabresi, P.5    Balducci, L.6
  • 36
    • 33749609130 scopus 로고    scopus 로고
    • Congestive heart failure (CHF) in older women treated with anthracycline (A) chemotherapy (C)
    • [abstract]
    • Giordano S.H., Pinder M., Duan Z., Hortobagyi G., and Goodwin J. Congestive heart failure (CHF) in older women treated with anthracycline (A) chemotherapy (C). Proc Am Soc Clin Oncol 24 (2006) 8s [abstract]
    • (2006) Proc Am Soc Clin Oncol , vol.24
    • Giordano, S.H.1    Pinder, M.2    Duan, Z.3    Hortobagyi, G.4    Goodwin, J.5
  • 37
    • 1542753592 scopus 로고    scopus 로고
    • Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices
    • Lyman G.H., Dale D.C., and Crawford J. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. J Clin Oncol 21 (2003) 4524-4531
    • (2003) J Clin Oncol , vol.21 , pp. 4524-4531
    • Lyman, G.H.1    Dale, D.C.2    Crawford, J.3
  • 38
    • 0019378585 scopus 로고
    • Dose-response effect of adjuvant chemotherapy in breast cancer
    • Bonadonna G., and Valagussa P. Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304 (1981) 10-15
    • (1981) N Engl J Med , vol.304 , pp. 10-15
    • Bonadonna, G.1    Valagussa, P.2
  • 39
    • 0032547342 scopus 로고    scopus 로고
    • Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B
    • Budman D.R., Berry D.A., Cirrincione C.T., Henderson I.C., Wood W.C., Weiss R.B., et al. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst 90 (1998) 1205-1211
    • (1998) J Natl Cancer Inst , vol.90 , pp. 1205-1211
    • Budman, D.R.1    Berry, D.A.2    Cirrincione, C.T.3    Henderson, I.C.4    Wood, W.C.5    Weiss, R.B.6
  • 40
    • 0035253733 scopus 로고    scopus 로고
    • Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial
    • French Adjuvant Study Group
    • French Adjuvant Study Group. Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial. J Clin Oncol 19 (2001) 602-611
    • (2001) J Clin Oncol , vol.19 , pp. 602-611
  • 41
    • 85074743625 scopus 로고    scopus 로고
    • Acute myeloid leukemia (AML) in older women after adjuvant breast cancer therapy
    • [abstract]
    • Patt D., Duan Z., Hortobagyi G., and Giordano S.H. Acute myeloid leukemia (AML) in older women after adjuvant breast cancer therapy. Proc Am Soc Clin Oncol 24 (2006) 17s [abstract]
    • (2006) Proc Am Soc Clin Oncol , vol.24
    • Patt, D.1    Duan, Z.2    Hortobagyi, G.3    Giordano, S.H.4
  • 42
  • 43
    • 0028156819 scopus 로고
    • The effect of co-morbidity on 3-year survival of women with primary breast cancer
    • Satariano W.A., and Ragland D.R. The effect of co-morbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120 (1994) 104-110
    • (1994) Ann Intern Med , vol.120 , pp. 104-110
    • Satariano, W.A.1    Ragland, D.R.2
  • 44
    • 0035925169 scopus 로고    scopus 로고
    • Effect of age and co-morbidity in postmenopausal breast cancer patients aged 55 years and older
    • Yancik R., Wesley M.N., Ries L.A., Havlik R.J., Edwards B.K., and Yates J.W. Effect of age and co-morbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285 (2001) 885-892
    • (2001) JAMA , vol.285 , pp. 885-892
    • Yancik, R.1    Wesley, M.N.2    Ries, L.A.3    Havlik, R.J.4    Edwards, B.K.5    Yates, J.W.6
  • 45
    • 4444315066 scopus 로고    scopus 로고
    • Probabilities of death from breast cancer and other causes among female breast cancer patients
    • Schairer C., Mink P.J., Carroll L., and Devesa S.S. Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96 (2004) 1311-1321
    • (2004) J Natl Cancer Inst , vol.96 , pp. 1311-1321
    • Schairer, C.1    Mink, P.J.2    Carroll, L.3    Devesa, S.S.4
  • 46
    • 0031901577 scopus 로고    scopus 로고
    • Co-morbidity and functional status are independent in older cancer patients
    • Extermann M., Overcash J., Lyman G.H., Parr J., and Balducci L. Co-morbidity and functional status are independent in older cancer patients. J Clin Oncol 16 (1998) 1582-1587
    • (1998) J Clin Oncol , vol.16 , pp. 1582-1587
    • Extermann, M.1    Overcash, J.2    Lyman, G.H.3    Parr, J.4    Balducci, L.5
  • 47
    • 33745611120 scopus 로고    scopus 로고
    • A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy
    • Hurria A., Hurria A., Zuckerman E., Panageas K.S., Fornier M., D'Andrea G., et al. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J Am Geriatr Soc 54 (2006) 1119-1124
    • (2006) J Am Geriatr Soc , vol.54 , pp. 1119-1124
    • Hurria, A.1    Hurria, A.2    Zuckerman, E.3    Panageas, K.S.4    Fornier, M.5    D'Andrea, G.6
  • 48
    • 0029865134 scopus 로고    scopus 로고
    • Estimating treatment benefits for the elderly: the effect of competing risks
    • Welch H.G., Albertsen P.C., Nease R.F., Bubolz T.A., and Wasson J.H. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med 124 (1996) 577-584
    • (1996) Ann Intern Med , vol.124 , pp. 577-584
    • Welch, H.G.1    Albertsen, P.C.2    Nease, R.F.3    Bubolz, T.A.4    Wasson, J.H.5
  • 49
    • 27244441470 scopus 로고    scopus 로고
    • Developing a cancer-specific geriatric assessment: a feasibility study
    • Hurria A., Gupta S., Zauderer M., Zuckerman E.L., Cohen H.J., Muss H., et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 104 (2005) 1998-2005
    • (2005) Cancer , vol.104 , pp. 1998-2005
    • Hurria, A.1    Gupta, S.2    Zauderer, M.3    Zuckerman, E.L.4    Cohen, H.J.5    Muss, H.6
  • 51
    • 24044454968 scopus 로고    scopus 로고
    • Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
    • Extermann M., Aapro M., Bernabei R., Cohen H.J., Droz J.P., Lichtman S., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55 (2005) 241-252
    • (2005) Crit Rev Oncol Hematol , vol.55 , pp. 241-252
    • Extermann, M.1    Aapro, M.2    Bernabei, R.3    Cohen, H.J.4    Droz, J.P.5    Lichtman, S.6
  • 53
    • 33746866643 scopus 로고    scopus 로고
    • Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective
    • Hurria A., Goldfarb S., Rosen C., Holland J., Zuckerman E., Lachs M.S., et al. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Breast Cancer Res Treat 98 (2006) 343-348
    • (2006) Breast Cancer Res Treat , vol.98 , pp. 343-348
    • Hurria, A.1    Goldfarb, S.2    Rosen, C.3    Holland, J.4    Zuckerman, E.5    Lachs, M.S.6
  • 55
    • 0037089630 scopus 로고    scopus 로고
    • How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials
    • Sateren W.B., Trimble E.L., Abrams J., Brawley O., Breen N., Ford L., et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20 (2002) 2109-2117
    • (2002) J Clin Oncol , vol.20 , pp. 2109-2117
    • Sateren, W.B.1    Trimble, E.L.2    Abrams, J.3    Brawley, O.4    Breen, N.5    Ford, L.6
  • 58
    • 0037687355 scopus 로고    scopus 로고
    • Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
    • Citron M.L., Berry D.A., Cirrincione C., Hudis C., Winer E.P., Gradishar W.J., et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21 (2003) 1431-1439
    • (2003) J Clin Oncol , vol.21 , pp. 1431-1439
    • Citron, M.L.1    Berry, D.A.2    Cirrincione, C.3    Hudis, C.4    Winer, E.P.5    Gradishar, W.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.